Chargement en cours...

长链非编码RNA在非小细胞肺癌EGFR-TKIs耐药中的研究进展

Most non-small cell lung cancer patients with active epidermal growth factor receptor (EGFR) mutation will eventually acquire drug resistant to EGFR tyrosine kinase inhibitors, such as gefitinib, resulting in disease progression, which involves a variety of complex mechanisms. Up to now, the molecul...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Zhongguo Fei Ai Za Zhi
Format: Artigo
Langue:Inglês
Publié: 中国肺癌杂志编辑部 2018
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5973017/
https://ncbi.nlm.nih.gov/pubmed/29526180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2018.02.06
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!